How innovation, advanced manufacturing, and expertise drive success in the evolving CDMO and generics landscape.

Biogen enhances its portfolio and margins amidst market challenges and competition. Click here to find out why BIIB stock is ...

The best value stocks have an attractive fundamental valuation, a healthy balance sheet, a stable or growing market share in ...

It is ideal to consider how well you fit within a company's culture before accepting a job. Ask specific questions during an ...

Artificial intelligence has already made its mark in commercial industries, and there's a good argument to be made that AI is most impactful in the drug discovery marketplace: — Goldman ...

About BioTechnique LLC BioTechnique is an American pharmaceutical contract research, development and manufacturing facility filling the need for therapeutic and highly potent sterile injectable ...

The Oncology Institute, Inc. (NASDAQ: TOI) Q4 2024 Earnings Call Transcript March 25, 2025 ...

We think CR Pharma has a weaker financial position compared with the top three medical distributors. Similar to other pharmaceutical distributors, accounts receivable make up a large portion of its ...

Total Revenues in 2024 reached $492 million, representing a 427% increase over prior yearProduct Revenues in 2024 reached $273 million, ...

R&D Expenses: Research and development expenses for the year ended December 31, 2024 decreased to approximately $2,044,000 compared to $3,297,000 for the year ended December 31, 2023. The decrease was ...

Munters will expand in Botetourt County, creating 270 jobs, Target will expand in New Kent County while McClung will upgrade ...

It also reduced 25% of its employees during the first quarter in an effort to reduce costs. The reduction is expected to save $15 million through 2027, Atea said. Write to Katherine Hamilton at ...